ICON: Accellacare Site Network expansion
ICON has expanded its Accellacare Site Network, with new partnerships aimed at increasing its geographical reach, supporting increased access to patients, and enhancing therapeutic capability. The expansion includes six research sites located in four different countries: US, Germany, Spain, and Poland.
“Enrolling and engaging patients in clinical trials continues to be one of the biggest challenges within drug development,” said Alison Liddy ICON’s senior vice president of site and patient solutions. “Our new Accellacare partnerships extend our ability to help customers enhance clinical trial feasibility and improve patient enrollment timelines in key therapeutic areas.”
